| 000 | 00662 a2200217 4500 | ||
|---|---|---|---|
| 005 | 20250514080658.0 | ||
| 264 | 0 | _c20031010 | |
| 008 | 200310s 0 0 eng d | ||
| 022 | _a0362-1332 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 245 | 0 | 0 |
_aFirst treatment for rare enzyme disorder. _h[electronic resource] |
| 260 |
_bFDA consumer _c |
||
| 300 |
_a6 p. _bdigital |
||
| 500 | _aPublication Type: News | ||
| 650 | 0 | 4 | _aDrug Approval |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aIduronidase _xtherapeutic use |
| 650 | 0 | 4 |
_aMucopolysaccharidosis I _xdrug therapy |
| 650 | 0 | 4 |
_aRecombinant Proteins _xtherapeutic use |
| 773 | 0 |
_tFDA consumer _gvol. 37 _gno. 4 _gp. 6 |
|
| 999 |
_c12738630 _d12738630 |
||